The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kurginyan Kh.M.

State Research Center of Preventive Medicine, Russian Ministry of Health, Moscow

Suvorov K.S.

State Research Center of Preventive Medicine, Russian Ministry of Health, Moscow

Clinical cases of effective use of rivaroxaban in venous thromboembolic complications management in patients with cancer and collagen diseases

Authors:

Kurginyan Kh.M., Suvorov K.S.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2015;(10): 73‑75

Views: 3083

Downloaded: 31


To cite this article:

Kurginyan KhM, Suvorov KS. Clinical cases of effective use of rivaroxaban in venous thromboembolic complications management in patients with cancer and collagen diseases. Pirogov Russian Journal of Surgery. 2015;(10):73‑75. (In Russ.)
https://doi.org/10.17116/hirurgia20151073-75

Recommended articles:
Opti­mal prevention of VTE in cancer surgery patients with impaired renal function. Piro­gov Russian Journal of Surgery. 2024;(1):119-126
Catheter-Directed Thro­mbolysis for Phle­gmasia Ceru­lea Dolens. Journal of Venous Diso­rders. 2023;(4):361-366
Main causes of premature mortality due to obesity. Russian Journal of Preventive Medi­cine. 2023;(12):52-57
Modern operative gyne­cology in geriatric patients. Russian Journal of Human Reproduction. 2024;(1):10-25
Embo­lism-Threatening Thro­mbosis: Is There Such a Problem?. Journal of Venous Diso­rders. 2024;(1):38-47
Endo­vascular Mana­gement of Iliofemoral Deep Vein Thro­mbosis. Journal of Venous Diso­rders. 2024;(1):64-71

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.